近期，一艘造型独特的"LV巨轮"在朋友圈刷屏，成为上海"新地标"，吸引诸多市民与游客拍照留念。暑期已至，为了让全球旅客在上海"好来、好玩、 好购"，上海将通过多项活动和服务，充分展现上海的夏日活力和魅力。 7月2日下午，上海市政府新闻办举行新闻发布会，市商务委主任朱民介绍2025"上海之夏"国际消费季的总体安排，市商务委副主任刘敏，市文化旅游 局、市体育局等相关领导共同出席新闻发布会，回答记者提问。 水芙蓉 摄 为境内外游客提供便利 记者了解到，"上海之夏"国际消费季是以促进暑期入境消费为主的城市活动品牌，首届活动期间，吸引境外旅客人数同比增长42.2%，外卡消费总额同 比增长68.2%。 今年上半年，上海入境消费市场持续火热，累计接待入境游客424.8万人次，同比增长38.5％；离境退税商品销售额同比增长85%，其中，"即买即退"服 务实现爆发增长，销售额同比激增28.1倍。 "入境消费的快速增长，不仅带来消费规模的扩大，更催生了多元细分需求。"上海市商务委主任朱民在发布会上表示，今年"上海之夏"将针对日韩、东 南亚、欧美等不同客源地游客特点，推出差异化消费场景，精准匹配全球旅客的消费偏好。 在出行方面，东 ...

美国总统特朗普：越南将为对美出口支付20%的关税；越南将向我们支付40%的转运关税。我们将能够 以零关税将我们的产品出口到越南。 特朗普：越南将为对美出口支付20%的关税 ...

"酒以成礼，酒以养老，酒以成欢"——《礼记》中的寥寥数语，早已道尽酒在华夏文明中超越物质的角 色。如今，当中华优秀传统文化的代表——茅台以"三个转型"为号角，推动白酒向社交属性与情绪价值 回归时，我们看到的不仅是一次品牌战略的调整，更是一场对中华酒文化本真的深情溯源与时代重构。 天工造物，酒之始，礼之源 酒的诞生，是自然馈赠的奇迹。中国酒文化漫长的演变中，在生活、社交、文学以及哲学层面都具有多 重功能的体现。 远古先民偶然发现，熟透坠地的野果在自然酵母作用下悄然转化，流淌出令人沉醉的芳醇。考古发现， 如河南贾湖遗址出土的陶器内壁残留物，证实了大约9000年前，人类已开始有意识地酿造类似酒的物 质。 现代商业浪潮席卷之下，白酒曾一度偏离其精神航道。杯盏交错间，酒本应承载的"礼之敬""养之 诚""欢之真"悄然褪色。当酒桌成为博弈场而非情谊场，酒文化最珍贵的灵魂——那份凝聚人心、传递 情意、滋养生活的本真价值，便在追逐中模糊了身影。 近年来，面对行业迷思，茅台积极探索客群转型、场景转型、服务转型，展开了一场意义深远的"价值 回归"实践，将酒重新锚定于"成礼、成欢"的古老坐标。坚持回归"酒以成礼、酒以成欢"的酒文化内 ...

Core Insights - Zacks Premium provides various tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores are designed to complement the Zacks Rank, helping investors identify stocks with the potential to outperform the market [3][4] Zacks Style Scores Overview - The Zacks Style Scores categorize stocks into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [4][5][6][7] - Value Score emphasizes finding undervalued stocks using financial ratios [4] - Growth Score assesses a company's financial health and future growth potential [5] - Momentum Score identifies trends in stock prices and earnings estimates [6] - VGM Score combines all three styles to provide a comprehensive evaluation of stocks [7] Zacks Rank and Performance - The Zacks Rank utilizes earnings estimate revisions to guide investors in stock selection, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8][9] - There are over 800 stocks rated 1 or 2, which can be overwhelming for investors [10] Stock Example: Annaly Capital Management (NLY) - Annaly Capital Management is a mortgage real estate investment trust (mREIT) with a diverse portfolio including mortgage-related securities [13] - NLY holds a 3 (Hold) rating on the Zacks Rank and has a VGM Score of B, along with a Value Style Score of B, indicating attractive valuation metrics [14] - The company has seen an upward revision in earnings estimates, with a Zacks Consensus Estimate of $2.87 per share for fiscal 2025 [14] - Given its solid Zacks Rank and favorable Style Scores, NLY is recommended for investors' consideration [15]

Core Insights - Zacks Premium provides tools for investors to enhance their stock market engagement and confidence, including daily updates, research reports, and stock screens [1] - The Zacks Style Scores serve as complementary indicators to the Zacks Rank, helping investors select stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores Overview - Stocks are rated based on value, growth, and momentum characteristics, with scores ranging from A to F, where A indicates the highest potential for outperformance [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] Value Score - The Value Score targets stocks that are undervalued based on various financial ratios, assisting value investors in identifying attractive investment opportunities [3] Growth Score - The Growth Score emphasizes a company's financial health and future growth potential, analyzing historical and projected earnings, sales, and cash flow [4] Momentum Score - The Momentum Score identifies stocks with favorable price trends, utilizing recent price changes and earnings estimate revisions to guide investment timing [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive assessment of stocks based on value, growth, and momentum [6] Zacks Rank and Performance - The Zacks Rank, which is based on earnings estimate revisions, has shown strong performance, with 1 (Strong Buy) stocks averaging a 25.41% annual return since 1988, significantly outperforming the S&P 500 [8] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to refine their selections [9] Stock Highlight: SkyWest (SKYW) - SkyWest is rated 2 (Buy) on the Zacks Rank and has a VGM Score of A, indicating strong investment potential [11] - The company has a forward P/E ratio of 11.2, making it attractive for value investors [11] - Recent upward revisions in earnings estimates for fiscal 2025 have increased the Zacks Consensus Estimate to $9.30 per share, with an average earnings surprise of 17.1% [12]

Core Insights - JPMorgan announced a plan to increase its quarterly dividend and authorized a new share repurchase program after clearing the annual stress test [2][5] - The bank's projected common equity tier 1 (CET1) ratio stands at 14.2%, significantly above the minimum requirement of 4.5%, indicating strong capital resilience [6][9] Dividend and Share Repurchase - JPMorgan intends to declare a quarterly dividend of $1.50 per share in Q3 2025, reflecting a 7% increase from the previous payout [3][9] - The company has increased its dividend five times over the past five years, with an annualized growth rate of 6.8% [3] - A new share repurchase program of $50 billion has been authorized, replacing the previous $30 billion plan [5][9] Financial Strength - As of March 31, 2025, JPMorgan reported total debt of $471.9 billion, with cash and deposits amounting to $425.9 billion, showcasing a strong balance sheet [7] - The bank's robust capital position and earnings strength support its ability to sustain enhanced capital distributions [7] Peer Comparisons - Other banks, including Bank of America and Goldman Sachs, also announced new capital plans following the stress test, indicating a broader trend in the industry [8][10][11] Market Performance - JPMorgan shares have increased by 21.2% year-to-date, outperforming the S&P 500 Index, which gained 4.8% [12] - The bank trades at a price-to-tangible book (P/TB) ratio of 3.07X, above the industry average [15] Earnings Estimates - The Zacks Consensus Estimate for JPMorgan's 2025 earnings suggests a decline of 6% year-over-year, while 2026 earnings are expected to grow by 5.3% [16]

Market Overview - Wall Street ended the first day of July 2025 on a mixed note, with the S&P 500 and Nasdaq falling while the Dow Jones Industrial Average gained slightly [1] - The contrasting movements in the major stock indices were influenced by opposing forces, including a feud between President Trump and Tesla CEO Elon Musk, and the U.S. Senate's passage of Trump's tax bill aimed at stimulating economic growth [2] Investment Opportunities - Amid market uncertainty, there is a potential opportunity to invest in low-leverage stocks that are not expensive and can provide a protective shield during turbulent times [3] - Suggested low-leverage stocks include Novartis (NVS), Alamo Group (ALG), ArcelorMittal (MT), Bilibili (BILI), and Sterling Infrastructure, Inc. (STRL) [3][10] Low-Leverage Stocks - Low-leverage stocks are characterized by a lower debt-to-equity ratio, indicating reduced financial risk and improved solvency [7][8] - Investing in low-leverage stocks is recommended to avoid significant losses during economic downturns [6][7] Company Highlights - **Novartis (NVS)**: Recently completed the acquisition of Regulus Therapeutics, enhancing its drug portfolio. The Zacks Consensus Estimate for NVS's 2025 sales suggests a 7.3% improvement from 2024, with a long-term earnings growth rate of 7.9% [15][16] - **Alamo Group (ALG)**: Completed the acquisition of Ring-O-Matic, expanding its product offerings. The Zacks Consensus Estimate for ALG's 2025 earnings indicates a 7.2% year-over-year improvement [17][18] - **ArcelorMittal (MT)**: Signed an agreement to sell operations in Bosnia and Herzegovina, allowing a focus on higher-growth areas. The company has a long-term earnings growth rate of 49.8% [19] - **Bilibili (BILI)**: Reported a 24% year-over-year revenue increase and a 58% improvement in gross profit for Q1 2025. The Zacks Consensus Estimate for its 2025 sales indicates a 12.1% improvement from 2024 [20][21] - **Sterling Infrastructure (STRL)**: Announced the acquisition of CEC Facilities Group, enhancing its service portfolio in high-growth markets. The company has a long-term earnings growth rate of 15% [22][23]

Core Insights - Applied Materials (AMAT) has achieved a gross margin of 49.2% in Q2 of fiscal 2025, marking the highest level since Q4 of fiscal 2000, driven by a favorable product mix and strong demand for high-margin solutions [1][10] - The demand for semiconductors, particularly in AI and high-performance computing (HPC), is increasing, positively impacting AMAT's leading-edge logic foundry solutions [2] - AMAT's Sym3 Magnum etch system has generated over $1.2 billion in revenue since its launch in February 2024, highlighting its importance in developing high-aspect-ratio structures for AI and HPC workloads [3] Financial Performance - AMAT's memory segment, particularly advanced DRAM technologies, is projected to grow significantly, with revenues from advanced DRAM customers expected to increase by more than 40% in fiscal 2025 [4] - For Q3 of fiscal 2025, AMAT anticipates a gross margin of 48.3%, indicating sustained strength in margins due to ongoing demand for high-performance computing and AI [5] - The company trades at a forward price-to-sales ratio of 4.94X, which is lower than the industry average of 8.5X, suggesting potential valuation upside [11] Competitive Landscape - AMAT faces competition from Lam Research (LRCX) and ASML Holding (ASML) in areas such as 3D DRAM architectures and EUV lithography, with both competitors experiencing growth in gross margins [6] - Lam Research is projecting a gross margin of 49.5% for the upcoming quarter, which would set a new record if achieved [7] Market Performance - AMAT's shares have increased by 13.3% year-to-date, outperforming the Electronics - Semiconductors industry, which has grown by 11.5% [8]

常熟农商行在江苏的三家新支行——南京江宁支行、宿迁宿城支行、扬州宝应支行日前相继揭牌开业， 作为村镇银行"改支"过程中的又一缩影，常熟农商行也凭借"跨行收编"实现了对南京等地的版图布局。 而这样的案例在近年来密集现身，据北京商报记者7月2日统计，仅在今年6月，就有近20家村镇银行获 准被吸收合并，改革重组工作加速，行业整合提质趋势明显。作为曾经农村金融"毛细血管"的村镇银 行，正经历从数量扩张到质量提升的关键转型。 "村改支"动作频频 当"常熟农商行南京江宁支行开业"的字样在电子屏循环滚动，宿迁宿城支行、扬州宝应支行完成揭牌， 三枚新的坐标，标志着常熟农商行"村改支"收编动作的落地。 根据常熟农商行最新披露的公告，该行已于6月26日获得监管批复，正式完成对江苏江宁上银村镇银 行、宿迁宿城兴福村镇银行、江苏宝应锦程村镇银行三家机构的吸收合并工作，并已在近日完成支行揭 牌开业。 从股权结构和整合模式来看，江苏宝应锦程村镇银行原本由成都银行作为主发起行设立，今年1月，常 熟农商行通过股权受让，实现对其100%控股，完成了从异地城商行到本地农商行的控制权转移；江苏 江宁上银村镇银行则由上海银行联合六家民营企业共同发起 ...

Company Overview - Biodesix is a leading diagnostics company focused on improving clinical care and patient outcomes[1, 12] - The company's mission is to transform patient care through personalized diagnostics that are timely, accessible, and address immediate clinical needs[13] - Biodesix envisions a world where patient diseases are conquered with the guidance of personalized diagnostics[14] Business Lines and Key Capabilities - Biodesix generates revenue through two business lines: Lung Diagnostic Tests and Development Services[15] - The company expects to have approximately 95 sales representatives focused on lung diagnostics in the field by 4Q25[19] - Biodesix boasts industry-leading gross margins of 794%[19] - Development Services had $109 million in contracts not yet recognized as of the end of Q1 2025[73] Lung Diagnostic Tests - Lung cancer accounts for approximately 1 in 5 cancer deaths annually in the USA[29] - Approximately 80% of patients assessed for lung cancer risk fall into the low to moderate risk category (5-65%)[37, 43] - The Nodify Lung test identifies likely malignant nodules with 78% PPV, 98% specificity, and 28% sensitivity, and identifies likely benign nodules with 98% NPV, 97% sensitivity, and 44% specificity[46] Financial Performance - Total revenue for Q1 2025 was $180 million, representing a 21% year-over-year growth[76, 78] - Lung Diagnostics revenue in Q1 2025 was $163 million, an 18% increase year-over-year[76, 81] - Development Services revenue in Q1 2025 was $17 million, a 61% increase year-over-year[76, 81]